reference/15400283

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15400283

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	573
issn	1556-0864
issueIdentifier	3
pageRange	567-573
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	567
bibliographicCitation	Belani CP, Wu YL, Chen YM, Kim JH, Yang SH, Zhang L, Peterson P, Orlando M. Efficacy and safety of pemetrexed maintenance therapy versus best supportive care in patients from East Asia with advanced, nonsquamous non-small cell lung cancer: an exploratory subgroup analysis of a global, randomized, phase 3 clinical trial. J Thorac Oncol. 2012 Mar;7(3):567–73. doi: 10.1097/jto.0b013e31823d4f9d. PMID: 22157370.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3611-0258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bda6fd05dc5cc250677f27121e132402 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e7d26603c7055513f5702f1709a8a8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea107a01d41d959ed722062b8471b32b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_445c654b648495d3b87dbcd7fd58361d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_361a47985fe9e135400da0145058b98d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caf6f9aea9e64c549fc72b3cb05cd6f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41f3855568922b229054144d63bd660e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc010e156a13806ae00368df24a7bacc
date	201203
identifier	https://doi.org/10.1097/jto.0b013e31823d4f9d https://pubmed.ncbi.nlm.nih.gov/22157370
isPartOf	https://portal.issn.org/resource/ISSN/1556-0864 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of Pemetrexed Maintenance Therapy versus Best Supportive Care in Patients from East Asia with Advanced, Nonsquamous Non-small Cell Lung Cancer: An Exploratory Subgroup Analysis of a Global, Randomized, Phase 3 Clinical Trial
discusses	http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0001471
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018287Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D005971Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010166 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D016879 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018287Q000401 http://id.nlm.nih.gov/mesh/D000230Q000401 http://id.nlm.nih.gov/mesh/D006147Q000627 http://id.nlm.nih.gov/mesh/D009364Q000401 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005202 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837

Total number of triples: 64.